Senior Director, Field HEOR

How You Will Achieve More:

The Senior Director, Field HEOR will play a critical role in shaping and executing our U.S. market access strategy with national and large regional commercial and government payers in preparation for our first gene editing therapy launch. This is a high-impact, field-based position responsible for building relationships with key payer stakeholders, communicating product value, presenting scientific evidence, and supporting the National Accounts team to achieve favorable coverage and reimbursement pathways.

This is a highly strategic, hands-on role that is ideal for an experienced HEOR professional who thrives in fast-paced, build-from-scratch environments and understands the complexity of launching innovative, high-value therapies.

Responsibilities:

• Payer Engagement: Present clinical, economic, and real-world evidence to payers to support favorable coverage and reimbursement decisions and policy development for Intellia therapies. Includes presentation of economic models, burden of illness data, budget impact analysis, real-world evidence (RWE) and clinical outcomes data.  Tailor clinical and economic messaging for field use across commercial and government segments.
• Account Support: Partner closely with National Account Directors on account planning, payer strategy, and evidence deployment to optimize payer engagement.  Serve as primary field-based scientific liaison for payer team to support discussions with Medical Directors, Pharmacy Directors, and other policy and formulary decision-makers.
• Training & Enablement: Train and mentor National Account Directors on health economics, outcomes research (HEOR) concepts, payer evidence, scientific support, and value messaging.
• Evidence Generation: Identify opportunities and partner with HEOR for payer-focused real-world evidence (RWE) collaborations, data projects, and outcomes research that can inform access strategy.
• Scientific Leadership: Stay abreast of scientific literature, clinical trial data, economic evaluations, and policy developments to strengthen Intellia’s access narrative.
• Congress Representation: Represent Intellia at major payer, HEOR, and scientific congresses, presenting evidence and engaging with external experts.
• Strategic Insights: Provide actionable insights from payer interactions to inform internal evidence generation, value proposition development, and overall access strategy including mitigation of coverage barriers.
• Value Proposition Development: Contribute to the creation and evolution of a compelling value proposition for Intellia’s therapies, aligning clinical innovation with payer needs.
• Launch Deliverables:  Collaborate with HEOR and support the development and adaptations of core access deliverables including the AMCP Dossier, Budget Impact Model (BIM), and cost-effectiveness models.
• Outcomes/ Value-Based Agreements:  Support the design of concepts, selection of meaningful endpoints, and tracking frameworks to enable innovative value-based agreements with payers.
• Cross functional Collaboration: Support internal functions on scientific exchange needs to shape coverage and reimbursement policies as well as payer utilization management strategies.

About You:

• Strong knowledge of payer decision-making, health economics methodologies, and value demonstration strategies.
• Experience engaging directly with payers and presenting clinical and economic evidence.
• Ability to identify and drive real-world evidence projects that address payer needs.
• Expertise in the development and/or deployment of payer launch deliverables
• Proven track record of success in both field-based HEOR roles (payer-facing) and in-house HEOR roles preferred.
• Demonstrated ability to partner cross-functionally with account teams, HEOR, medical affairs, and clinical development.
• Excellent communication, presentation, and interpersonal skills.
• Prior experience in rare disease, cell/gene therapy, or advanced therapeutics preferred.
• BS/BA and Advanced degree (e.g., MPH, PhD, PharmD, MD, MS in Health Economics, Outcomes Research, Public Health, or related field).
• 10+ years of experience in HEOR, market access, or payer strategy within the pharmaceutical/biotech industry.
• Minimum 5+ years HEOR payer facing experience or prior field HEOR/ payer medical; prior experience supporting value based contracting discussions preferred.
• Demonstrated knowledge of payer evidence needs particularly with high-cost, specialty or gene therapies covered under medical benefit.
• Strong grasp of healthcare policy, reimbursement systems (Commercial, Medicare, Medicaid) and medical policy development.

#LI-KO1

#LI-Remote

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down.

The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors.

Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion.

For more information about Intellia’s benefits, please click here.